Chongqing Genrix Biopharmaceutical Co., Ltd. Class ASSE: 688443

Announcement on Renewing Engagement of Audit Institution for 2026

· Issued by Chongqing Genrix Biopharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Renewing Engagement of Audit Institution for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment